CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the When, where, and how to target vascular inflammation in the post-CANTOS era? Association Between Depressive Symptoms and Incident Cardiovascular Diseases Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials Comparison of 1-month Versus 12-month Dual Antiplatelet Therapy after Implantation of Drug-eluting Stents Guided by either Intravascular Ultrasound or Angiography in Patients with Acute Coronary Syndrome: Rationale and Design of Prospective, Multicenter, Randomized, Controlled IVUS-ACS & ULTIMATE-DAPT trial Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease
|<<... 127 128 129 130 131 132 133 ...>>|

Clinical Trial2019 Mar 18. [Epub ahead of print]

JOURNAL：N Engl J Med. Article Link

Coronary Angiography after Cardiac Arrest without ST-Segment Elevation

Lemkes JS, Janssens GN, van der Hoeven NW et al. Keywords: ischemic heart disease; out-of-hospital cardiac arrest; immediate coronary angiography; delayed angiography ; PCI; non STEMI; survival; 90 days

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top